Related Experiment Videos

beta-Amyloid peptides induce degeneration of cultured rat microglia

A R Korotzer1, C J Pike, C W Cotman

  • 1Department of Psychobiology, University of California, Irvine 92717.

Brain Research
|October 8, 1993
PubMed

Insights

Assembled beta-amyloid peptides cause degeneration and metabolic dysfunction in microglia, key brain immune cells. Non-assembled peptides do not harm these cells, suggesting aggregate form is critical in Alzheimer's disease pathology.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglia, the brain's immune cells, are associated with senile plaques in Alzheimer's disease (AD).
  • Senile plaques contain insoluble beta-amyloid (A beta) protein aggregates.
  • Assembled A beta peptides are known to cause neuronal damage in vitro.

Purpose of the Study:

  • To investigate the effect of assembled A beta peptides on microglia in vitro.
  • To determine if A beta peptide aggregation is necessary for microglial degeneration.

Main Methods:

  • Cultured microglia were exposed to assembled synthetic A beta peptides.
  • Microglial cultures were also exposed to non-assembling scrambled sequence A beta peptides.
  • Morphological and metabolic changes in microglia were assessed.

Main Results:

  • Assembled A beta peptides induced morphological degeneration in process-bearing microglia.
  • Metabolic dysfunction was observed in microglial cultures exposed to assembled A beta peptides.
  • Non-assembling scrambled sequence A beta peptides did not cause these effects.

Conclusions:

  • Aggregated beta-amyloid peptides directly damage microglia.
  • Microglial degeneration and dysfunction may contribute to Alzheimer's disease pathogenesis.
  • The aggregation state of A beta is critical for its toxicity to microglia.

Related Concept Videos